Mark Levin, Partner at Third Rock Ventures, Boston, Massachusetts, United States — verified investor profile. See sector focus and contact routes.
Third Rock Ventures discovers, launches, builds, and transforms companies. They have 73 portfolio companies and 26 marketed products, focusing on patient priority. They operate from Boston, MA, and San Francisco, CA. Their portfolio includes companies in areas such as oncology (Tango Therapeutics, Synnovation Therapeutics, INLEXZO), genetic hearing loss (Otarmeni), anemia (Aqvesme), mental health (Syremis Therapeutics), precision genome engineering (Azalea Therapeutics), and cardiovascular health (Element Science), as well as precision immunology (Merida Biosciences).
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Mark Levin · Full investor directory · Investor access · Company funding database